Massage for generalized anxiety: brain imaging and response
Part of Mental health clinical trials.
This study tests if massage therapy can help people with generalized anxiety disorder (GAD) and uses brain scans to see how it works. You may join if you have GAD, are not on certain medications or are stable on them, and can lie face down or face up for an hour.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 64 years old.
- You have been diagnosed with generalized anxiety disorder (GAD).
- Your anxiety scores are high enough (at least 15 on a standard anxiety questionnaire).
- You are not taking psychiatric medications, or you have been on a stable dose for at least 6 weeks.
- You can lie flat on your stomach or back for one hour at a time.
- You are not a regular massage recipient (no more than 3 massages per year for the last 5 years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests whether electroacupuncture (a type of acupuncture with mild electrical pulses) can help treat Generalized Anxiety Disorder (GAD). It also uses brain scans (MRI) to see how the treatment might work.
This study tests a non-invasive brain stimulation technique (cTBS) to treat Generalized Anxiety Disorder. You will receive navigated stimulation sessions, and no surgery or medication is used.
This study tests a noninvasive brain stimulation treatment called continuous theta burst stimulation (cTBS) for adults with generalized anxiety disorder (GAD). It aims to see if this treatment can reduce anxiety symptoms and possibly offer a new option for people who have not responded well to other treatments.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests whether an already-studied medication, SEP-363856, can continue to safely help adults with generalized anxiety disorder over a longer period. It may offer ongoing symptom relief for people who completed a previous study of this drug.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.